Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,535 AUD | +0,94% |
|
-9,32% | 0,00% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 01-05-12 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Thomas Jarrett
COO | Chief Operating Officer | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-12 |
Justin Ward
BRD | Director/Board Member | - | 01-01-16 |
Director/Board Member | - | 29-11-17 | |
Daniel Astudillo
SAM | Sales & Marketing | - | 01-04-18 |
Maggie Niewidok
SEC | Corporate Secretary | - | 01-09-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Prendergast
CHM | Chairman | 70 | 24-04-18 |
Alan Dunton
BRD | Director/Board Member | 70 | 14-07-20 |
Director/Board Member | - | 29-11-17 | |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-12 |
James Graham
CEO | Chief Executive Officer | - | 01-05-12 |
Justin Ward
BRD | Director/Board Member | - | 01-01-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 203 701 863 | 125 491 504 ( 61,61 %) | 0 | 61,61 % |
Bedrijfsgegevens
Recce Pharmaceuticals Ltd.
Salesforce Tower 180 George Street
2000, Sydney
+61 2 9256 2505
http://www.recce.com.au![Adres Recce Pharmaceuticals Ltd(RCE)](https://cdn.zonebourse.com/static/address/24446338.png)
Sector
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
0,00% | 71,77 mln. | |
+54,68% | 815 mld. | |
+44,25% | 654 mld. | |
-6,19% | 354 mld. | |
+21,32% | 337 mld. | |
+11,03% | 302 mld. | |
+18,45% | 247 mld. | |
+2,09% | 229 mld. | |
+13,03% | 219 mld. | |
+8,93% | 171 mld. |